Brief: VYNE Therapeutics FY Revenue USD 501 Thousand
Mar 06 (Reuters) - VYNE Therapeutics FY net income USD -39.834 million. FY basic EPS USD -0.93 FY EPS from cont ops USD -0.93
Mar 06 (Reuters) - VYNE Therapeutics FY net income USD -39.834 million. FY basic EPS USD -0.93 FY EPS from cont ops USD -0.93